Brief: Oric Pharmaceuticals Reports Second Quarter 2022 Financial Results And Operational Update
11/08/2022 22:01
Aug 11 (Reuters) - Oric Pharmaceuticals Inc ORIC.O :
* ORIC PHARMACEUTICALS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND OPERATIONAL UPDATE
* CASH AND INVESTMENTS OF $237.8 MILLION EXPECTED TO FUND
CURRENT
OPERATING PLAN INTO 2H 2024
* QTRLY LOSS PER SHARE $0.51
* Q2 EARNINGS PER SHARE VIEW $-0.60 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX8wmmhz
Further company coverage: ORIC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ORIC Pharmaceuticals
See all newsBrief: Oric® Pharmaceuticals Announces Agreement With Cancer Research UK
ORIC Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: ORIC Pharmaceuticals Q1 Operating Expenses USD 39.619 Million
Brief: Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ORIC Pharmaceuticals Q4 loss narrows